Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lifshitz Law PLLC Announces Investigations of IMGN, HA, CERE, and EVFM

HA, EVFM, CERE

NEW YORK, NY / ACCESSWIRE / December 13, 2023 / Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of IMGN to AbbVie, Inc. for $31.26 in cash per share of IMGN owned.

ImmunoGen, Inc. (NASDAQ:IMGN)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of IMGN to AbbVie, Inc. for $31.26 in cash per share of IMGN owned.

If you are an IMGN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516) 493-9780 or e-mail at info@lifshitzlaw.com.

Hawaiian Holdings, Inc. (NASDAQ:HA)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with sale of HA to Alaska Air Group, Inc. for $18.00 in cash per share of HA owned.

If you are a HA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516) 493-9780 or e-mail at info@lifshitzlaw.com.

Cerevel Therapeutics Holding Inc. (NASDAQ:CERE)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of CERE to AbbVie Inc. for $45.00 in cash per share of CERE owned.

If you are a CERE investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516) 493-9780 or e-mail at info@lifshitzlaw.com.

Evofem Biosciences Inc. (OTCQB:EVFM)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of EVFM and Aditxt Inc.

If you are an EVFM investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516) 493-9780 or e-mail at info@lifshitzlaw.com.

ATTORNEY ADVERTISING. © 2023 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@lifshitzlaw.com

SOURCE: Lifshitz Law Firm, P.C.



View the original press release on accesswire.com